12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

BioCryst board of directors update

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C.
Business: Cancer, Endocrine/Metabolic,...

Read the full 21 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >